Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Contour Health Tirzepatide Review: Cost, Pay-Per-Vial & Honest Verdict (2026)

An honest 2026 review of Contour Health tirzepatide — a named 503A pharmacy, pay-per-vial pricing with no subscription required, and a terms contradiction.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Bodybuilding Health+

The Bodybuilding.com fitness brand's new compounded arm — tirzepatide bundles down to $244/month on a year, alongside semaglutide, NAD+, sermorelin, and peptides.

$319/mo ($244/mo on 12-mo bundle)

Check Bodybuilding Health+ availability

Contour Health: $300/month for its starting-dose tirzepatide, and has a genuinely working LegitScript verification checker linked directly from the site's own badge — a real, checkable verification step most competitors skip. Every fact here comes from the company's own published program.

What Contour Health is

Contour Health (Desert Contour LLC) is a Utah-based telehealth provider, offering compounded semaglutide and tirzepatide through a named 503A pharmacy partner, Strive Pharmacy — a real transparency signal. Care is overseen by a board-certified Medical Director and a named nurse-practitioner team, not anonymous providers.

§ Contour Health — Marketing vs. Terms of Service

ItemStatus
Tirzepatide$300/mo starting dose
Named pharmacyStrive Pharmacy, 503A
Subscription claimMarketing says none; ToS describes an optional 3-month-minimum tier
Verified: $300/mo, working LegitScript checker. Terms of Service describe an optional subscription despite "no subscriptions" marketing.

What Contour Health costs

Tirzepatide starts at $300/month at the starting dose. Pricing is structured as pay-per-vial, with no long-term subscription commitment required to participate — a genuinely more flexible structure than the multi-month prepay plans common elsewhere in this category. A free medical consultation is included, with no charge to talk with a provider before starting.

A real terms-vs-marketing contradiction

Worth flagging directly: Contour Health's marketing emphasizes "no subscriptions", but its own Terms of Service also describe an optional subscription tier with a 3-month minimum — a contradiction worth clarifying directly before assuming the pay-per-vial model is your only option.

The brand-vs-compounded question

Contour Health dispenses compounded injectable tirzepatide only — no oral option, no brand-name Wegovy, Zepbound, Ozempic, or Mounjaro. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Contour Health's real strengths: a genuinely working LegitScript verification checker, plus a free medical consultation, pay-per-vial pricing with no required subscription, a named 503A pharmacy (Strive Pharmacy), and a named Medical Director and NP care team. The trade-offs: the state availability list isn't published — Terms of Service only say "certain states" — all product purchases are non-refundable, it's compounded injectable only, the "no subscriptions" marketing contradicts an optional subscription tier described in the Terms of Service, and no insurance, Medicare, or Medicaid is accepted. As with any GLP-1 program, and especially one with a marketing-vs-terms discrepancy, read the actual Terms of Service before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Contour Health's genuinely working LegitScript checker and named pharmacy are real trust signals, and pay-per-vial pricing is a genuine flexibility advantage — just read the Terms of Service directly, since the "no subscriptions" marketing doesn't fully match an optional subscription tier described there. If a simpler, contradiction-free flat rate matters more to you, compare it against CoreAge Rx or BiltRx. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Contour Health?

$300/month at the starting dose. Pricing is pay-per-vial with no long-term subscription required.

Does Contour Health name its compounding pharmacy?

Yes — Strive Pharmacy, a 503A-accredited partner.

Does Contour Health really have no subscriptions?

Its marketing says so, but its own Terms of Service describe an optional subscription tier with a 3-month minimum — read the terms directly before assuming pay-per-vial is your only option.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.